Discover 901 paid clinical trials in Birmingham, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 901
A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)
for
Neoplasms, Endometrial
Location: Birmingham AL, Charlottesville VA, Sugar Land TX,
Sponsor: GlaxoSmithKline
Sex: Female
Age: 18+
Code: NCT07286331
Phase 3, Recruiting
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
for
Ulcerative Colitis, Crohn's Disease
Location: Birmingham AL, Atlanta GA, Mobile AL, Southaven MS,
Sponsor: Takeda
Sex: All
Age: 18 - 70+
Code: NCT06581328
Phase 4, Recruiting
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
for
Hormone Receptor Positive HER-2 Negative Breast Cancer,
Location: Birmingham AL, Atlanta GA, Nashville TN,
Sponsor: Puma Biotechnology, Inc.
Sex: All
Age: 18+
Code: NCT06369285
Phase 2, Recruiting
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
for
Cancer
Location: Birmingham AL, Atlanta GA, Carterville IL,
Location: Birmingham AL, Atlanta GA, Corbin KY, Covington LA,
Sponsor: Paradigm Health
Sex: All
Age: 18+
Code: NCT06605404
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
GEMINI-NSCLC: NSCLC Biomarker Study
for
Non-Small Cell Lung Cancer
Location: Birmingham AL, Atlanta GA, Memphis TN, Carterville IL,
Sponsor: Tempus AI
Sex: All
Age: 18+
Code: NCT05236114
Recruiting
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Birmingham AL, Atlanta GA, Nashville TN, Greenville SC,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07518186
Phase 3, Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
for
Paroxysmal Atrial Fibrillation
Location: Birmingham AL, Atlanta GA, Mobile AL, Louisville KY,
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Sex: All
Age: 18+
Code: NCT06324201
Recruiting
Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients